Emyria Limited (ASX:EMD)
Australia
· Delayed Price · Currency is AUD 0.0470
-0.0010 (-2.08%)
At close: Mar 6, 2026
Emyria Revenue
Emyria had revenue of 1.55M AUD in the half year ending December 31, 2025, with 42.67% growth. This brings the company's revenue in the last twelve months to 2.29M, up 29.34% year-over-year. In the fiscal year ending June 30, 2025, Emyria had annual revenue of 1.39M, down -36.68%.
Revenue (ttm)
2.29M
Revenue Growth
+29.34%
P/S Ratio
16.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.91M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PainChek | 3.44M |
| Vitasora Health | 5.01M |
| Beamtree Holdings | 28.90M |
| TrivarX | -95.36K |
| ImExHS | 29.00M |
| Mach7 Technologies | 29.69M |
| Resonance Health | 13.79M |
| PharmX Technologies | 7.65M |